CHTR vs EBS
Charter Communications Inc (CHTR) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CHTR and EBS stock pages for the full models.
Not investment advice.